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Fatty Acid Concentration and 
Phase Transitions Modulate Aβ 
Aggregation Pathways
Pratip Rana1, Dexter N. Dean2, Edward D. Steen3, Ashwin Vaidya3, Vijayaraghavan 
Rangachari2 & Preetam Ghosh  1
Aggregation of amyloid β (Aβ) peptides is a significant event that underpins Alzheimer disease (AD) 
pathology. Aβ aggregates, especially the low-molecular weight oligomers, are the primary toxic 
agents in AD and hence, there is increasing interest in understanding their formation and behavior. 
Aggregation is a nucleation-dependent process in which the pre-nucleation events are dominated by 
Aβ homotypic interactions. Dynamic flux and stochasticity during pre-nucleation renders the reactions 
susceptible to perturbations by other molecules. In this context, we investigate the heterotypic 
interactions between Aβ and fatty acids (FAs) by two independent tool-sets such as reduced order 
modelling (ROM) and ensemble kinetic simulation (EKS). We observe that FAs influence Aβ dynamics 
distinctively in three broadly-defined FA concentration regimes containing non-micellar, pseudo-
micellar or micellar phases. While the non-micellar phase promotes on-pathway fibrils, pseudo-
micellar and micellar phases promote predominantly off-pathway oligomers, albeit via subtly different 
mechanisms. Importantly off-pathway oligomers saturate within a limited molecular size, and likely 
with a different overall conformation than those formed along the on-pathway, suggesting the 
generation of distinct conformeric strains of Aβ, which may have profound phenotypic outcomes. Our 
results validate previous experimental observations and provide insights into potential influence of 
biological interfaces in modulating Aβ aggregation pathways.
Aggregation of Aβ constitutes the central process in Alzheimer disease (AD) pathology. Brains of AD patients 
contain large amounts of proteinacious plaques mainly comprised of insoluble Aβ fibril deposits. Monomeric 
Aβ peptides (Aβ40 and Aβ42) spontaneously undergo aggregation towards large fibrils in a nucleation depend-
ent manner. The effects of nucleation on aggregation dynamics have been extensively studied1–8 that point to a 
key rate-limiting step for the formation of nucleus/nuclei9–13. Therefore, the dynamics associated with reactions 
leading up to nucleation is critical for aggregation. Energetically, the pre-nucleation phase is nebulous with mon-
omers and oligomers (dimers, trimers etc.) involved in a dynamic flux dominated by stochastic interactions14–16. 
Furthermore, intrinsic disorder and amphipathic nature of Aβ facilitate multiple phase transitions and hetero-
geneous interactions during nucleation, making the process particularly sensitive to environmental factors such 
as pH, ionic strength, temperature and other interacting partners17–22. This is significant because smaller, soluble 
aggregates have emerged as the primary neurotoxic agents responsible for memory loss in AD23–26. Furthermore, 
it is clear that oligomers may not be the obligatory intermediates to fibril formation, and that the oligomers can 
also be populated along alternate pathways of aggregation (off-pathways)22, 27–32. Off-pathway oligomers differ 
from those formed along the on-pathway resulting in multiple conformational variants with distinct biochemical 
and cellular properties. Given the conformational diversity among oligomers, it is imperative to determine the 
factors that affect dynamics involved in such oligomer formation to establish a framework of molecular mecha-
nisms that better defines amyloid progression.
One class of biologically important interacting partners that affect Aβ pre-nucleation dynamics are the ani-
onic surfactants such as fatty acids and lipids33–39. Lipids and fatty acids are profoundly important in physio-
logical contexts as they are abundant in both brain tissues and CSF40, 41. The amphipathic Aβ peptide is known 
to have strong affinity for membranes and hence, these interactions may affect the pre-nucleation dynamics. 
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Several reports also demonstrate the effects of phospholipids on Aβ aggregation42–44. Similarly, both polyunsatu-
rated (PUFAs) and saturated fatty acids are also known to have significant effects on the AD brain45, 46. Kumar 
and co-workers have previously reported the generation of 4–5 mers and 12–24 mers from lauric acid along 
a non-fibril formation pathway22. More importantly, using carbon chain lengths of C9-C12 fatty acids (FAs), 
they established that below (non-micellar), near (pseudo-micellar) and above (micellar) their respective critical 
micelle concentrations (CMCs), FAs generate Aβ oligomers or fibrils via distinct pathways22. A schematic of the 
switching dynamics from on- to the off-pathway with increasing concentration of FAs is shown in Fig. 1. Here 
the bold horizontal arrow signifies increasing FA concentration while the vertical arrows conceptually depict the 
dynamical aggregation regimes of the system with the inclusion of monomeric Aβ. It can be observed that low 
FA concentration involves the non-micellar phase where only the on-pathway reactions are active; while high 
FA concentration (beyond the CMC) involves the micellar phase where only the off-pathway reactions are active 
(with on-pathway being completely switched off). The middle phase of the FA concentration arrow denotes the 
near-CMC (i.e., pseudo-micellar) phase and is the most interesting one; here, both on- and off-pathway reac-
tions are active and the monomeric Aβ may form aggregated oligomers from both pathways simultaneously (as 
denoted by the arrows).
In this report, we sought to understand the dynamics of heterotypic interactions between Aβ and FAs and 
how phase transitions of FAs modulate Aβ aggregation. We first use a reduced order model (ROM) and a cor-
responding mathematical analysis rooted in a linear stability argument to identify the switching behavior from 
on- to off-pathway in the presence of micellar interfaces. The ROM can be thought of as a toy-version of the far 
more complex biophysical problem. However, despite considering only 4-species in this model, the ROM still 
deals with a highly non-linear problem which captures the overall aggregation dynamics of the Aβ system and 
allows for rigorous examination of features such as dynamic stability which would be intractable in the case of a 
very fine grained model. Mathematical biologists consistently simplify complex biological problems to gain initial 
insight into problems, to understand the nature of equilibria, stability, bifurcations in the larger system, before 
venturing to speak of specific details which is the objective of the ROM. This analysis was used as the basis to fur-
ther develop a more detailed model, which was built around the discoveries of the ROM and experimental data.
Secondly, using an ensemble kinetic simulation (EKS) model, we demonstrate that in three distinct 
phase-transition regimes, FAs significantly and consistently modulate Aβ aggregation by altering the pathways. 
These results are in agreement with the reported in vitro experimental observations, and provides detailed molec-
ular insights into the heterotypic interactions between Aβ and FAs. These insights also reveal that generation of 
conformationally-distinct oligomeric strains (produced by the oligomers involved in the on- and off-pathways) 
are highly likely in physiological environments containing lipid and FA interfaces due to the dynamics involved 
in the heterotypic FA-Aβ interactions.
Results
Stability analysis for a reduced order model (ROM). We examined the sets of on- and off-pathway 
reactions shown below. The model system considered is as follows:
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where the reaction 2 is referred to the on-pathway, while reaction 3 is the off-pathway. In these reactions, A1 
denotes the Aβ monomers while A1′ denotes the off-pathway monomers created in the presence of fatty acids, FA 
(considering critical micelle concentration, CMC). An are the on-pathway oligomers while ′An are the off-pathway 
oligomers made of n monomeric units. Finally, ki
+ and ki
− are the forward and backward rate constants of the 
Figure 1. Schematic of the switching dynamics between the on- and off-pathways.
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corresponding reactions (i = 1, 2, 3). The details of the modeling methodology are elaborated in the Methods 
section. We are aware that the on-pathway fibrils are considerably larger than the terminal species of the 
off-pathway, i.e. size of (An) ≫ size of (A′n) or n ≫ n′. In the ROM analysis however, both pathways terminate at 
the same value of n since we believe this to be sufficient to elucidate the competition between the two pathways in 
our model. Since the only “bridge” from the on- to off-pathway is between the monomeric species, once the reac-
tion chooses the path from →A An1 , the on-pathway dominates in the steady state (or vice-versa) and higher 
order oligomer dynamics do not reveal anything more about the process. The asymmetric nature of the two path-
ways is however, considered in our follow-up analysis to understand detailed mechanistic phenomena.
Based on the results of our analysis presented in the Methods section, Fig. 2 shows the eigenvalues λi (i = 1–4), 
of the Jacobian matrix for the mass action kinetic equations (18–21). These eigenvalues appear as a function of α3, 
a normalized parameter which depend on the CMC and rate constants. The eigenvalues depict the rate of decay 
of any perturbation to the stable, non-zero equilibria of the system of equations (18–21). It so happens that the 
critical parameter α3 is key to determining whether the on-pathway or off-pathway is dominant. The Fig. 2 shows 
some significant events in the dynamics of this system. As α3 is increased from zero, the real part of the eigenval-
ues λi are all negative, indicating that the equilibria are stable. When α3 < 1.0, we observe that λ2 < λ1. However, 
when α3 > 1.0, it follows that λ2 > λ1 indicating an exchange in the magnitude of the stability. For α3 > 1.0, the 
species B1 (dimensionless version of A1) dominate in magnitude and also become more stable than B1′ (dimen-
sionless version of ′A1), indicating a transcritical-like bifurcation at α3 = 1.0.
Note that in the dynamical systems literature, transcritical bifurcation refers to a stable equilibrium and an 
unstable equilibrium which exchange stabilities with respect to some parameter47. In our model system, the 
switching of stabilities is revealed by α3, which, by its definition, contains the ratio of the forward to backward rate 
constants for this reaction, as well as the fatty acid concentration which enhances the formation of the off-pathway 
species. Figure 3(b) shows the rate of reformation of the species Bn and ′Bn, which is slower than the monomeric 
species.
Another interesting phenomenon that occurs in this system is a discontinuity in the eigenvalues or second 
switching which occurs at around α3 = 1.87 (see Fig. 3(a)). The Table 1 in the Supplementary Information cap-
tures the variety of switching behaviors and changes in behavior of the ROM system when different parameters 
(rate constants) are varied. At this stage, the biophysical implication of this second critical point is unclear to us 
although it is most certainly a symptom of the high nonlinearity of the system.
We explore the effect of n on our system, for 1 ≤ n ≤ 20. Our analysis reveals significant changes to the sta-
bility of the system as n varies; in particular, the eigenvalues λ1 and λ2 show some dramatic changes with n. For 
1 ≤ n < 12, multiple switching points (at least two) were observed with λ2 eventually being more negative than λ1, 
i.e. off-pathway eventually becomes more stable for sufficiently large α3. However, for 12 ≤ n ≤ 20, the on-pathway 
eventually becomes more stable. The physical significance of the multiple switching, in particular the one beyond 
α3 = 1 still eludes us and it remains to be verified if this an indication of some underlying bifurcation in the system 
or is simply an artifact of the nonlinear system or an indication of some nucleation type event observed in our 
previous work using similar methods48.
The results of our stability analysis with support from the Nash equilibrium for this system (see Methods 
section), allows us to draw the following conclusions: (i) The simplified, though highly nonlinear system of ROM 
equations with 4-species captures the essential dynamics of the Aβ system and can help explain the switch-
ing dynamics considering only the CMC; (ii) The non-dimensional parameter α3 is seen to be the key control 
parameter in this analysis indicating that FA concentration, along with the ratio of the rate constants along this 
Figure 2. The two panels in this figure depict the eigenvalues of the ROM Jacobian matrix B as a function of FA 
concentration, denoted by the parameter α3. Case (a) shows the eigenvalues of the monomeric species B1 and ′B1  
as a function of α3, which reveals multiple switching in the strength of the stability of the two species. Panel (b) 
shows the eigenvalues of the species Bn and ′Bn. Here both the oligomers maintain their relative stability profile 
for all α3. Note that Bis and B si′  refer to the normalized versions of Ais and A′is, for i = 1, n.
www.nature.com/scientificreports/
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“bridge” reaction pathway determine the ultimate fate of the system. (iii) The presence of a second, discontinuous 
switching of eigenvalues at α3 ≥ 1.87 potentially indicates a different biophysical phenomenon occurring along 
the off-pathway implicating the involvement of additional species that may play an important role in the FA 
dynamics. To explore the dynamics between on- and off-pathways of Aβ aggregation, we then conducted a more 
detailed ensemble simulation using chemical kinetics under varying concentration of FAs.
Ensemble kinetic simulation (EKSs) on Aβ-FA dynamics. In order to further investigate the dynam-
ics between the on- and off-pathways in the presence of FAs, we used the EKS approach. EKS approach involves 
numerical ordinary differential equation (ODE)-based simulations that encompasses ensembles of the dynamic 
species involved in the reaction flux. Fundamental aspects of EKSs were used in the on-pathway model that we 
Figure 3. The figure depicts the population of all four species, monomers and oligomers, in the ROM as a 
function of time. In its initial state, only the on-pathway monomers (B1) are taken to exist which reveals itself in 
the declining trend of B1s and an increase in the other species over time. The evolution of the monomers and 
aggregates is depicted for four different values of α =
+
−
k FA
k3
1
1
 while the remaining parameters in these cases 
correspond to the baseline case α1 = β1 = 0.1, α2 = β2 = 100 and n = 4. The inset shows a zoomed in version of 
the same plot to clearly show the initial phase of evolution. In each of the figures, the black filled circles 
represent B1, the open circles represent ′B1 , The x-shaped symbols corresponds to Bn and open triangles, to Bn′.
Carbon chain 
lengths of fatty acids
diameter (nm) at 
above-CMC range
diameter (nm) at 
near-CMC range
C9 2 14–16
C10 2.7 13.5–19
C11 3.2 16–22.5
C12 3.8 19–27
Table 1. Size difference between FApm and FAm for different carbon chain lengths of FAs determined by 
dynamic light scattering.
www.nature.com/scientificreports/
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had previously reported10, 48. In this report, we have expanded the EKS model to simulate various phase-transition 
regimes of FAs and Aβ, especially along off-pathway (elaborated in the Methods section). Before modeling on- 
and off-pathway dynamics, it is imperative to simulate the phase-transitions of FAs during micelle formation. 
We specifically chose three concentration regimes at which FAs show distinct phase changes: low concentrations 
where the FAs are non-micellar (FAn), near their CMCs where they are pseudo-micellar (FApm), and high con-
centration where they are fully micellar (FAm). We conjecture the nomenclature, pseudo-micelles to define the 
dynamic state between a non-micelle and a micelle, which seemed to affect Aβ in a distinct way22. The hydrody-
namic radii (Rh) estimates of FApm and FAm indicated that the former is ~6–7 times larger than the latter, confirm-
ing the loosely-held, amorphous state of FApm (Table 1).
Dynamics in non-micellar phase - Aβ–FAn interactions. First, for the control experiment in the absence of FAs 
(on-pathway reactions, exclusively), we find the forward rate constants during the nucleation stage (knuon) is 
considerably lower than the forward rate constant (kfbon) of elongation stage, as expected (Fig. 4(a)). The sim-
ulated data showed good correlation with the experimental data with an R2 value of 96.2, and an equally good 
agreement in the lag times (Fig. 4(a)) for C12, as well as C9-C11 FA data (Fig. 4(b)). The estimated rate con-
stants for control, i.e., on-pathway, are shown in Supplementary Table 2 in Appendix-B under Supplementary 
Information. Secondly, in the presence of FAn, on-pathway reactions still dominate due to the absence of micelles 
(or pseudo-micelles) in the solution. We hypothesize that FAns interact with Aβ and catalyze aggregation by alter-
ing the rate constants along the on-pathway by a factor of K, resulting in a change in the final fibril concentration. 
The corresponding set of reactions for this model are shown in Appendix-C under Supplementary Information. 
We obtain the value of K < 1 for the best fit with the experimental data pointing to a slowdown in the elongation 
stage of the on-pathway (Supplementary Table 3 in Appendix-C under Supplementary Information).
Figure 4. Experimental and simulated data at control and below CMC concentration. (a) For C12 FAs; Black 
squares: Experimental ThT intensity for on-pathway; Black line: simulated ThT intensity for on-pathway; Red 
triangles: Experimental ThT intensity for below-CMC set-up; Red line: simulated ThT intensity for below-CMC 
set-up; (b) Below-CMC experimental ThT intensity and simulated intensities for C9-C11; (c) Below-CMC semi-
log concentration ratio for A A/4 4′ , i.e., the 4-mers from off-pathway and on-pathway respectively considering 
monomer entry rates; the oligomer concentration were recorded at 50th, 100th and 200th hours for C12 fatty 
acids; (d) Oligomer concentration ratios between below CMC (Ai
FAn) and on-pathway (Ai) set-ups designated 
by A A/i
FA
i
n ; Red: (A1 at below-CMC)/(A1 at control); Blue: (A4 at below-CMC)/(A4 at control); Yellow: (A8 at 
below-CMC)/(A8 at control); Green: (A12 at below-CMC)/(A12 at control).
www.nature.com/scientificreports/
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The simulations of Aβ interactions with C12 FAn when compared to the on-pathway fibril growth character-
istics, provided two important observations. First, the overall aggregation was augmented with the introduction 
of FAn, consistent with the overall ThT intensity observed in experiments (Fig. 4(a); red). Second, the third phase 
of fibril growth curve (i.e., the slower growth phase towards saturation subsequent to the exponential growth 
phase) was delayed for a considerable amount of time with C12 FAn (as opposed to the on-pathway), despite no 
change in the lag time (Fig. 4(a)). We hypothesize these effects are caused by the introduction of FAn, which mod-
ulate the on-pathway rate constants. To test this hypothesis, we systematically analyzed the effects that FAn may 
have on the rates of on-pathway reactions at critical times of the aggregation process. First, the forward rate con-
stants during the pre-nucleation stage was altered (increased/decreased) by a factor of K, which did not fit the 
fibril growth curve for the C12 FAn case and concomitantly could not validate this behavior (data not shown). 
Next, upon varying the forward elongation rate constant (kfbon), a small decrease in the forward elongation rate 
constant render higher ThT intensity with delayed saturation time, and without changing the lag time. This sug-
gests that the addition of FAn molecules effectively decrease the forward elongation rate constants. According to 
the Lee’s and our own on-pathway models48, 49, the elongation stage (ie. + A A A12 1 12; +A A A12 2 12; … 
and A A A12 11 12+ ) does not lead to the increase in ThT intensity directly as these reactions may not increase 
the number of ThT binding sites significantly to augment fluorescence intensities. Hence, a decrease in the elon-
gation rate constant essentially extends the duration of the pre-nucleation stage, although without increasing the 
lag time. This subsequently could increase the formation of pre-nucleated on-pathway aggregates (specifically 
12 mers, i.e., A12s) resulting in higher ThT intensity/fibril growth. The increased number of A12s resulting from 
these reactions then react with one another as well as the on-pathway oligomers during the pre-nucleation stage 
(monomers to 11 mers, i.e., A1–A11) to generate higher order aggregates with concomitant higher ThT intensities. 
The predicted K value for different initial FAn concentrations is shown in Supplementary Table 3 in Appendix-C 
under Supplementary Information. Similar corresponding plots for ThT vs simulations for C9-C11 FAn are shown 
in Fig. 4(b). The high R2 values obtained for the fits (Supplementary Table 3) suggest that FAns promote 
on-pathway fibrils by a slightly different mechanism as compared to the Aβ aggregation in the absence of FAs. 
Hence, as shown in Fig. 4(c), the ratio of ′A4/A4 is effectively zero.
We further consider two hypothetical but physically relevant scenarios in which varying rates of entry of Aβ 
monomers and FAs were considered as opposed to a fixed concentration50. The reaction models for this scenario 
were then minimally modified to consider these additional entry rates as variables to evaluate the oligomer con-
centration dynamics. As expected in Fig. 4(c), the interaction of FAn with Aβ generated no off-pathway oligomers 
due to the absence of micelles or pseudo-micelles. Only on-pathway aggregates were formed exclusively, although 
by a slightly different mechanism. Based on these results, we determine that FAns decrease the rates during the 
fibril elongation stage along the on-pathway, which seems to hold good for each type of FA used (C9-C12).
In (Fig. 4(d)), we report the oligomer ratios (of the same size) between the control and FAn set-ups. We con-
sidered four oligomers for this test: A1, A4, A8, A12; in each case, these ratios rise above the value of 1, showing that 
the presence of more below-CMC oligomers than on-pathway oligomers in the system as time increases. Note 
that these were generated from two stand-alone simulations, one for the control and the other one for FAn as in 
both cases only on-pathway oligomers are produced. The results clearly suggest that the FAn scenario produces 
more oligomers (and possibly more fibrils) with time which supports the experimental observation of increased 
ThT intensity for FAn. Additionally, as expected the ratios are smaller for larger oligomers; this is simply because 
of the reaction order as fewer oligomers of larger size are formed in the system. Thus our reaction hypothesis of 
a slowdown of the elongation stage in the presence of FAns, although counter-intuitive, accurately validates the 
experimental observations of increased ThT intensity.
Dynamics in pseudo-micellar phase - Aβ/FApm interactions. FA concentration around the CMC increases the 
concentration of FApm in the bulk solution, the presence of which shifts the reaction flux towards predominantly 
off-pathway as established experimentally22, 51 (Fig. 1). As the forward elongation rate constant becomes crucial 
only at the later phase of the on-pathway reactions, the effect of K was neglected here. This allowed us to assume 
that effectively all FAs convert to FApms and thus making the effects of free FAs during the on-pathway elongation 
stage negligible. The predicted rate constants from the control experimental data were used here for the 
on-pathway set of reactions, and the parameter space was iterated to only estimate the rate constants involving 
off-pathway reactions. Thus, our combined on- and off-pathway model was able to explain all the experimental 
observations in the presence of FApm (corresponding R2 values are reported in Table 2 for C9-C12 FAs). 
Furthermore, previous reports identified that 12–24 mers (LFAOs) are the predominant species generated in the 
presence of C12 FApm22, 51. Our simulations predict the presence of multiple conformers within the oligomer of a 
Fatty acid CMC (mM)
Experimental concentration 
in (mM) from ref. 22 R2
Predicted pseudo-micelle 
concentration (μM)
C12 7 5 95.5 11
C11 22 20 92.5 16
C10 50 50 88.8 45
C9 85 100 91.1 8
Table 2. Relation of CMC, deviation from CMC with Experimental Fatty acid concentration, and predicted 
pseudo-micelle concentration; additionally reported are the R2 fit between simulation and experimental ThT 
intensity.
www.nature.com/scientificreports/
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specific size (strains) as observed before52. The 12–24 mer LFAOs show conformational dynamics (represented as 
′F1  and ″F1  here), wherein the F1′, and not ″F1 , is able to associate with itself. Note that both species ( ′F1  and F1″) 
correspond to 12–24 mer LFAOs and we considered up to four-fold lateral associations between them to form F4′ 
which are essentially 48–96 mers as previously established52. Such F4′ LFAOs then undergo a secondary fragmen-
tation to produce four F1″ which are not allowed to laterally associate thereby making the 12–24 mers as the pre-
dominant species. This is due to subtle yet distinct structural differences between the two 12–24 mer LFAOs53. In 
our model, we identified that lateral association and fragmentation are both critically important in Aβ/FApm 
reaction dynamics, which ultimately explains the formation of stable oligomers of size 12–24 i.e., ″F1 . The pre-
dicted concentration of pseudo-micelles are shown in Table 2 while the predicted rate constants and shown in 
Supplementary Table 4 in Appendix-D under Supplementary Information.
Overall simulation of the ThT intensity data for FApm regime yielded good correspondence with the experi-
mental results for C12 (Fig. 5(a); green). We obtained a high R2 value and nearly similar correspondence with the 
experimental lag time and saturation time for C12 as well for C9-C11 FAs (Fig. 5(b)). The comparative concentra-
tion dynamics of off-pathway and on-pathway aggregates in the presence of FApm are shown in Fig. 5(c–f) for C12 
fatty acid. Figure 5(e) is the data for constant FApm and varying Aβ monomer entry rates while Fig. 5(f) is the data 
obtained for constant monomers and varying FApm entry rates. In our model, for the sake of simplicity and com-
parison, we considered aggregates of similar sizes from both on- and off-pathway. We observe that the on-pathway 
oligomers A4, A7 and A12 show delayed emergence (Fig. 5(c)). It is noteworthy that A4 emerges rapidly, and satu-
rates before decreasing in concentration. This behavior is due to the elongation of oligomers by A12s that occurs 
along the on-pathway, which form larger fibrils at the cost of A4 consumption. Along the off-pathway, aggregates 
A4′, ′A8 and A12′  show expected characteristics of being formed rapidly initially before saturating (Fig. 5(d)). It is 
important to note that the elongation in the off-pathway leads to ′F1  consuming ′A4 and A12′  oligomers to form the 
12–24 mers as discussed previously. Such ′F s1  then associate to form ′F4 which are seen in greater quantities 
towards the beginning with their concentration decreasing with time, which is likely due to fragmentation of high 
molecular weight aggregates. Finally, most of the FApm dynamics leads to the formation of the ″F1  with time, which 
becomes the predominant ThT positive species in the system. This dynamics is further corroborated by incorpo-
ration of physiologically relevant monomer entry rates into the system (Fig. 5(d)). Here, the dynamics show more 
conclusively the dominance of the ″F1  oligomer in the system with increasing time followed by A8′ and ′A4. In order 
to verify the potential fragmentation identified by our simulation, we investigated this possibility experimentally 
by incubating Aβ and C12 FA near its CMC (Fig. 6). The results indicate that incubation rapidly results in the 
formation of aggregates corresponding to 50–60 nm diameter within one hour of incubation (Fig. 6(a) and (b)). 
However, after two hours of incubation, the size of the aggregates decreased to 10 nm diameter. No more change 
in the aggregate size was observed even after 48 h (data not shown). This phenomenon was also observed in the 
aggregate size monitored by immunoblotting (Fig. 6(c)), and supports the possibility of fragmentation of aggre-
gates as predicted by the EKS model predictions.
Figure 5(e) and (f) show the ratio of the oligomer distributions for C12 fatty acids considering constant entry 
rates of Aβ monomers with fixed initial FApm concentration (Fig. 5(e)) and FApm into the system for fixed initial 
monomer concentration (Fig. 5(f)), respectively, as described before for FAn. These plots illustrate the switching 
behavior between the on- and off-pathways as predicted by the ROM stability analysis (Figs 2 and 3). For example, 
we can observe that for negligible monomer or FApm entry rates, the on-pathway is active, but the switching 
occurs quickly to off-pathway when the monomer entry rate is about 0.001 × 100 μM h−1 (Fig. 5(e)). This switch-
ing effect is however faster when the FApm entry rate is considered as shown in Fig. 5(f) (the amplitude of the 
″F A/1 12 ratio is higher in the latter case). Also, the ratios are higher after 50 h of incubation as compared to after 
100 or 200 h (Fig. 5(e) and (f)). This suggests that either the F1″ concentration decreases with time or the A12 
increases with time or both cases happen simultaneously. As shown in Fig. 5(d), the increase in A12 is more pro-
nounced that that in ″F1  concentration with time (note that both concentration increase with time) resulting in a 
decrease in the recorded ratio with time. Nevertheless, we can conclude that generally the switch to off-pathway 
is extremely fast with higher FApm entry rates being a more crucial factor than an increase in the monomer entry 
rates for the observed effect.
Comparing the FApm ThT intensity plots (Fig. 5(b)), we additionally observe that the concentration of FApm 
significantly affects the behavior of aggregation. For example, higher the FApm concentration present in the sys-
tem (correlates with smaller fatty acid chain length), more the saturation is delayed for the ThT growth curve. As 
expected, our predicted FApm concentration is highest near the CMC, and the concentration starts to decrease 
when total FA concentration is either increased or decreased. The predicted FApm concentration for each fatty 
acid chain length at the near CMC zone experiments is shown in Table 2. Note that the prediction for the C9 case 
shows a small deviation primarily because the experiment was done at a 100 mM concentration while the actual 
CMC was 85 mM, i.e., a deviation of 17.6%.
Dynamics in micellar phase - Aβ − FAm interactions. The above-CMC regime (FAm) only produces ′A4 along the 
off-pathway that do not seem to aggregate any further due to the stabilization by the micelles22 (Fig. 7(a)). 
Therefore, the corresponding reaction model only considers the pre-nucleation stage in the off-pathway. 
Furthermore, the A4′ oligomers do not bind to ThT and hence, are invisible to this assay. This complicates the 
precise predictions of A4′ concentrations and direct correlation with the experimental data. Therefore, we could 
not estimate the accurate rate constants for FAm. It is noteworthy that we assumed the off-pathway reactions in the 
presence of FApm also undergoes similar pre-nucleation stage reactions besides others. The rate constants of the 
pre-nucleation stage from FApm data was used for this simulation to determine the dynamics of ′A4 production. As 
shown in Fig. 7(b) and (c), one could observe that A4′ is generated rapidly accompanying a switching to the 
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off-pathway, even with negligible monomer or micelle entry rates. As the A4′ formation presumably involves a 
concerted single step reaction, the concentration profile is different from its on-pathway counterpart, A4. 
Specifically, as micelle entry rate increases, number of micelles in the system also increases such that the A4′ con-
Figure 5. Experimental and simulated data at near CMC concentration: (a) and (b). Comparisons of the 
concentration of important oligomers between on- and off-pathways considering monomer, pseudo-micelle 
and micelle entry rates into the system: (c–f); the oligomer concentration were recorded at 50th, 100th and 200th 
hours for C12 fatty acids. (a) Green circles: Experimental ThT intensity for near-CMC set-up; Green line: 
simulated ThT intensity for near-CMC set-up; Black squares: Experimental ThT intensity for on-pathway; Black 
line: simulated ThT intensity for on-pathway; (b) Near-CMC experimental ThT intensity and simulated 
intensities for C9-C11; (c) Oligomer concentration plot for C12 fatty acids at the near-CMC range with 25 μM 
monomers (i.e., A1); (d) Oligomer concentration for C12 fatty acids at the near-CMC range considering 
0.1 μM/h rate of entry of A1 into the system; (e) Near-CMC semi-log concentration ratio for F A/1 12″ , i.e., the 
structurally distinct 12-mers from off-pathway undergoing secondary fragmentation and the 12-mers from on-
pathway respectively considering monomer entry rates; (f) Near-CMC semi-log concentration ratio for ″F A/1 12, 
considering pseudo-micelle (denoted by FApm) entry rates.
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centration increases much faster than that of the A4 concentration as shown in Fig. 7(c). However, Fig. 7(c) sug-
gests that for a fixed initial micelle concentration, and as the Aβ monomer entry increases, the ratio of ′A A/4 4 goes 
towards saturation. This is potentially due to reduction in the number of micelles available for accommodating 
Aβ on the micellar surface.
Discussion
The results reported here by two independent methods (ROM and EKS) reaffirm the experimental observa-
tions that FAs modulate Aβ aggregation. Specifically, the following significant conclusions can be drawn from 
this work: (a) interactions of Aβ with non-micellar FAs (FAn) generate predominantly high molecular weight, 
on-pathway aggregates. (b) Interactions of Aβ with FAs near the latter’s CMC (FApm) generate predominantly low 
molecular weight oligomers (12–24 mers) along off-pathway along with some minor quantities of on-pathway 
fibrils. (c) Interactions of Aβ with high concentrations of FAs (FAm; above their CMCs) exclusively generate 
off-pathway 4–5 mer oligomers without any fibrils suggesting that the on-pathway was completely turned off.
Perhaps most significantly, simulations from both ROM and EKS, as well as the previously demonstrated 
experimental evidence have identified that both concentration and phase-transitions of FAs dictate switching 
of Aβ aggregation pathways. Furthermore, the report demonstrates that under three distinct phases, FAn, FApm, 
and FAm, the FAs not only modulate Aβ aggregation pathways but also promote low molecular weight oligomers, 
which are increasingly known to be the main pathogenic species in AD and other related neurodegenerative 
disorders. Specifically under pseudo-micellar conditions, where FApm undergoes a distinct phase transition, they 
preferentially promote and stabilize low-molecular weight oligomers. The ability of certain phases of FAs, or in 
general any biological surfactants, to promote the formation of low molecular weight, off-pathway presents high 
significance in AD pathology. This is because oligomers generated in this manner could lead to the formation of 
various toxic ‘conformeric strains’ of Aβ aggregates, which could manifest in distinct phenotypic manifestations 
Figure 6. Dynamics of Aβ interaction with C12 FA. (a) Size of the aggregates estimated by DLS after 15 (black) 
and 30 (red) minutes of incubation at 37 °C, along with data after 1 (orange), 1.5 (blue), 2 (pink), 2.5 (green) 
and 3 (yellow) hours of incubation, respectively. (b) Variations in diameter (nm) for each time point, calculated 
from data in panel (a). (c) SDS-PAGE with immunoblotting of LFAO formation at 37 °C from 0 to 24 hours, 
respectively. The amount loaded into each lane was kept constant at 1.1 μg.
Figure 7. Experimental (points) and simulated (lines) ThT intensities at (a) Above-CMC concentration; Black: 
on-pathway; Blue line: simulated ThT intensity at above-CMC set-up. (b) Above-CMC semi-log concentration 
ratio for ′A A/4 4, i.e., the 4-mers from off-pathway and on-pathway respectively considering monomer entry 
rates; (c) Above-CMC semi-log concentration ratio for A A/4 4′ , considering micelle (denoted by FAm) entry rates.
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observed in AD. Indeed, Dean et al., have shown that LFAOs, which are generated in the presence of C12 FAs, 
are able to propagate morphologically distinct fibrils and caused excessive cerebral amyloid angiopathy (CAA) in 
transgenic mice brains, which was absent in similar reactions seeded with on-pathway fibrils52.
Mechanistically, simulations reported here have revealed a deeper understanding of Aβ-FA interactions. Some 
of the salient dynamics involved in the modulation of Aβ aggregation by FAs in distinct phases include: (i) in the 
presence of FAn, the free FAs seem to slow the kinetics of elongation (or post-nucleation) stage along the 
on-pathway, (ii) in the presence of FAm, aggregation does not proceed beyond ′A4 (or A5′) likely due to the stabili-
zation of Aβ by FAm as Aβ-FAmm complex. Further investigation of this complex by molecular dynamics based 
studies to infer why such complexes cannot aggregate is on-going and will be reported at a later date, and (iii) in 
the presence of FApm, Aβ forms A4 during the pre-nucleation phase followed by a slower progression to ′A12, and 
elongation to form 12–24 mers denoted by F1′. Association of F1′ to form F4′, which is thermodynamically unstable, 
leads to a fragmentation to form F1″ as supported by experimental evidence (Fig. 6). The most likely possibility is 
that the F1″ are structurally distinct and different from ′F1  that are trapped in some kinetic minimum along the 
off-pathway as thought to be22, 51, which renders them incapable of aggregating further.
In addition to these insights, EKS model also considered a physiological scenario in which instead of constant 
amount or Aβ or FAs, a constant influx of Aβ monomers as well as pseudo-micellar and micellar FAs were con-
sidered. Incorporating specific entry rates for Aβ and FAs, we observe that the presence of pseudo-micellar phase 
influences the switching of pathways more than that induced by the monomers. However, we observed that even 
a slight increase in the entry rates of either FA or Aβ is enough to switch the dynamics preferentially towards the 
off-pathway. This is evident in Fig. 8, which shows a surface plot which considers the monomer and FApm/FAm 
rates. The corresponding oligomer concentration ratios along off- and on-pathway show that the on-pathway is 
active only when FApm entry rates are very low (Fig. 8(a) and (b)). After 50 h of incubation, off-pathway is pre-
dominantly activated for the highest FApm entry rate and low monomer entry rates. In other words, all monomers 
entering the system are consumed by FApm leaving little scope for on-pathway reaction to occur. However, after 
Figure 8. On- and Off-pathway switching dynamics at near-CMC and above-CMC zones considering Aβ and 
pseudo-micelle entry rates for C12 fatty acid. (a) switching dynamics at near-CMC zone at the 50th hour; (b) 
switching dynamics at near-CMC zone at the 200th hour; (c) switching dynamics at above-CMC zone at the 50th 
hour; (d) switching dynamics at above-CMC zone at the 200th hour.
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200 h, off-pathway is most active when both FApm and monomer entry rates are high resulting in most monomers 
being consumed by the FApm. The scenario is bit different for FAm, where the off-pathway is most active when 
both monomer and FAm entry rates are high both after 50 and 200 h (Fig. 8(c) and (d)). The dynamics seems to be 
more stable after 200 h than after 50 h, as oligomer concentrations saturate by then. However after 50 h, a switch 
to off-pathway happens only with sufficiently high Aβ monomer and FAm entry rates, and there may be a critical 
point in this entry rate for both that would dictate whether a switch to the off-pathway occurs or not. In later 
times though (200 h, for example), there is a higher propensity of the system to switch to the off-pathway even 
with lower monomer or micelle entry rates.
Overall, this report has brought forth several interesting observations on the dynamics of Aβ-FA interactions, 
which seems to depend critically on the concentration and phase of FAs. Furthermore, the switching dynamics in 
conjunction with the constant infusion of Aβ monomers and FAs in their distinct phases illustrate the potential 
of biological interfaces to influence Aβ into forming several different conformationally distinct aggregates. Such 
conformeric strains could then influence phenotypic outcomes in AD pathology.
Methods
Experimental. Preparation of large fatty acid-derived oligomers (LFAOs). C12:0 fatty acid (5 mM) with 
50 mM NaCl was added to freshly purified Aβ monomer (50 μM) buffered in 20 mM Tris, pH 8.0, and kept at 
37°C in quiescent conditions. Separate reactions were started in a staggered fashion such that at the time of data 
collection, the sample would reach the desired time point.
Dynamic light scattering (DLS). DLS data was collected using a Zetasizer Nano S instrument (Malvern, Inc., 
Worcestershire, UK). At each time point, DLS was collected by averaging 24 runs of 5 s each with a pre equili-
bration time of 30 s. This average was used to determine the diameter (nm) using the volume (%) function. For 
determining micelle size without Aβ, stock concentrations of C9:0, C10:0, C11:0, and C12:0 were diluted to the 
appropriate concentration in 50 mM NaCl buffered in 20 mM Tris, pH 8.0.
SDS-PAGE with immunoblotting. LFAO preparations were staggered in start such that at the time of initiating 
SDS-PAGE experiments, each sample was at the desired time point. Samples were diluted into 1X Laemmli load-
ing buffer with 1% SDS, and loaded onto 4–20% BioRad TGX gels without boiling. Pre-stained MW markers 
(Novex Sharp Protein Standard, Life Technologies) were run in parallel for MW determination. Proteins were 
transferred to 0.2 μm nitrocellulose membrane (BioRad) and boiled for 1 min in a microwave oven in 1X PBS, 
followed by blocking for 1.5 h in 1X PBS containing 5% nonfat dry milk with 1% tween 20. Blots were then probed 
overnight at 4 °C with a 1:6000 dilution of Ab5 monoclonal antibody, which detects amino acids 1–16 of Aβ. Blots 
were then incubated with a 1:6000 dilution of anti-mouse, horseradish peroxidase conjugated secondary antibody 
and developed with ECL reagent (Thermo Scientific).
Reduced Order model (ROM). The system of differential equations corresponding to Eqns 1 determines 
the evolution of the 4 species ( ′ ′ ′A A A A, , ,n n1 1 ) and are given by
= − + ′ −− + − +
dA
dt
nk A nk A k A k A FA (4)n
n1
2 2 1 1 1 1 1
dA
dt
nk A nk A k A k A FA (5)n
n1
3 3 1 1 1 1 1
′
= ′ −
′
−
′
+− + − +
= − +− +
dA
dt
k A k A (6)
n
n
n
2 2 1
′
= − ′ + ′− +
dA
dt
k A k A (7)
n
n
n
3 3 1
The above equations are better suited for analysis in non-dimensional form. If we chose the characteristic 
concentration and time as A0 (the equilibrium concentration of monomers) and k
1
1
− , respectively, then the dimen-
sionless variables can be defined as follows:
Table 3. A sample game-theoretical payoff matrix to depict the on- and off-pathway competition. The cells 
highlighted in blue represent the Nash equilibrium.
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The corresponding dimensionless differential equations, in terms of dimensionless time ‘s’, now can be written as
α α α= − + −′
dB
ds
n B n B B B (9)n
n1
1 2 1 1 3 1
β β α= − + −
′
′ ′ ′dB
ds
n B n B B B (10)n
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1 2 1 3 1 1
α α= −
dB
ds
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n n
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β β= −
′
′ ′dB
ds
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Equilibrium points. In the equations (4–7), if we consider the limit k k FA( , , ) (0, 0, 0)1 1 →
+ − , then the 
off-pathway dynamics is turned off, leaving only the reaction
⋅ .
−
+
n A A
k
k
n1
2
2
However, the on-pathway cannot be switched off and always persists. In this case the equilibrium solution is 
given by the pair 






+
−( )A A, kk n0 0 1/22 .
Turning our attention now to the more general case of the non-dimensional equations (9–12), the equilibrium 
points, = ′ ′B B B BB ( , , , )e e e n e n e1, 1, , ,  can be obtained by the vanishing of the equations (9–12). Solving for these four 
simultaneous equations, we obtain the following relations, in terms of the equilibrium concentration B1,e
B B B B B B; ;
(13)n e e
n
e e n e
n
e
n
,
2
1
1, 1, 3 1, ,
2 3
1
1,
α
α
α
β α
β
= ′ = ′ = .
The subscript e indicates that these species are in equilibrium.
It should also be noted that if one treats the on- and off-pathway dynamics as a “competition” in accordance 
with the term used in game-theory54, 55, then the equilibrium B Be Nash e1 ,3
=
α =
 is nothing but the Nash equilib-
rium of the system given by
B B B BB : , , ,Nash e e e e
n
e
n
, 1, 1,
2
1
1,
2
1
1,
α
α
β
β
=





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(see Fig. 3 for an example of such an equilibrium). This equilibrium exists only at α3 = 1 which also will be seen to 
have special significance in terms of the stability of the system. It follows that when α3 > 1, then the off-pathway 
species dominate creating more equilibrium concentrations of ′B e1,  and for α3 < 1, on-pathway dominates result-
ing in greater production of B e1, .
We define k k FA1=
+ +  and k k1=
− − so that the former leads to off-pathway and the latter to on-pathway. 
Table 3 below points to a sample case of the various strategies in the competition between the two pathways with 
the pay-off for each “strategy” given by the equilibrium concentrations.
Time evolution of the different species. The system of equations (4–7) were solved using the Matlab ode45 function. 
A sample solution is shown in Fig. 2 corresponding to initial conditions: B (0) 21 = , ′ = = ′ =B B B(0) (0) (0) 0n n1 , 
11 1α β= = , 12 2α β= =  and n = 4. Also, here α = 13  which results in B Be e1, 1,= ′ .
Linear stability analysis. To study the stability of the four species, we linearly perturb the system which is math-
ematically represented by
B B X (14)e1 1, 1ε= +
B B Y (15)e1 1, 1ε′ = ′ +
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then the linearized set of differential equations for the perturbations, at o(ε) becomes
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which can be expressed in operator form with the perturbation matrix, B given by
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The stability of the equilibrium is found from computing the eigenvalues, λi (i = 1, 2, 3, 4) of the matrix B. This 
is best done numerically. In the figures below we discuss the results of the computations. In particular, the term 
α3 is varied throughout the analysis since it captures a significant dynamical feature of this problem; the switching 
from on-pathway to off-pathway. Over all, we choose the following ranges for our parameters: 
10 , 10i i
10 10α β≤ ≤−  for i = 1, 2. Also, n1 20≤ ≤  and B1 20e1,≤ ≤ . We begin with the base case defined by the 
choice 0 11 1α β= = . , 1002 2α β= = , n = 4 and B1,e = 1 and then study the sensitivity of the system and our 
results to each of the parameters.
Ensemble Kinetic Simulations (EKS) of on- and off-pathways. Experimental observations and model 
assumptions. The detailed simulations and subsequent analysis are based on prior work where the in-vitro 
experiment using the non-esterified fatty acids of chain length C9 to C12 revealed a few crucial characteristics of 
Aβ42 aggregation22:
 1. At FA concentration less than CMC range (FAn), only on-pathway aggregates were produced. Furthermore 
an increase in ThT intensity than the control experiment was detected.
 2. At near CMC (FApm), off-pathway fibrils of length 12–24 mers were noticed with very few fibrils being 
produced leading to the conclusion that the on-pathway was almost switched off.
 3. At FA concentration higher than CMC (FAm), off-pathway oligomers of length 4–5 mers were observed 
while no fibrils were produced, i.e., the on-pathway was switched off completely.
Before establishing a proper modeling of the off-pathway, we wish to explore the formation of micelles first. 
Ideally, CMC is the concentration of the surfactants (here, FAs) in the solution from where the micelle formation 
starts. Therefore, if high concentration of surfactants are introduced into the solution (FAm), it directly forms 
micelles. At FAn and FApm concentrations, ideally there should not be any micelles present in the solution whereas 
at FAm range, almost all of the FAs should convert into micelles. As discussed earlier, at FApm, the FAs loosely form 
pseudo-micelles that are six-seven times larger than regular micelles. It can hence be hypothesized that as the FA 
concentration is increased beyond the CMC, extra FA molecules bind to the pseudo-micelles, which may then 
undergo structural change to form more stable and compact structured micelles (i.e., L) that were considered in 
the ROM model.
Based on the experimental observations, we make the following considerations to formulate the underlying 
reaction mechanism.
 1. At FAn range, only on-pathway reactions take place, as in this zone no micelles are present in the solution. 
We assume that the presence of FAs have catalytic effects in altering the rate constants of the on-pathway 
with a factor of K resulting in a change in the final fibril concentration; the corresponding set of reactions 
are shown in Appendix-C under Supplementary Information.
 2. At FAm concentrations, both on-pathway and off-pathway occur simultaneously; however, as seen in the 
ROM model, the existence of micelles can switch the Aβ monomers more towards the off-pathway 
aggregates. We further assume that one micelle binds four Aβ monomers at once to form the off-pathway 
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species ′A4; such A4′ oligomers cannot aggregate any further. This is because our experimental observations 
at FAm range point to the formation of A s4′  which do not aggregate to form fibrils.
 3. Similarly at FApm range, both on- and off-pathway reactions occur simultaneously. The reaction mecha-
nism for ′A4 oligomer formation is similar as in the previous step. However, in this case the oligomer A4′ 
further aggregates to form 12–24 mers.
On-pathway reaction model. The on-pathway reaction model is motivated by our previous works in 
refs 9, 10, 47, 52, 56. Here, two different sets of reactions are considered. Firstly, the Aβ monomers form higher 
order aggregates (A12) through monomer addition and eventually form fibrils; the modeling abstraction consid-
ers A12 as fibrils, F. These reactions mainly depend on the monomer concentration and are slow being termed as 
pre-nucleation. Next, the higher order oligomers (A12) react with the monomers and other on-pathway aggregates 
(A2, …, A11) and get elongated. The rates of these reactions depend on both monomer and fibril concentration. 
The pre-nucleation stage is slower, whereas the elongation phase is rapid, thereby causing the sigmoidal growth 
of the fibril concentration over time. The nucleation number of on-pathway reactions is taken as 12 as reported in 
ref. 48; these reactions are shown in Appendix-B under Supplementary Information.
FAn reaction model. At the FAn range, we assume the reactions to be exactly similar to the on-pathway model; 
however the rate constants for each phase of the sigmoidal ThT growth curve were varied by a factor of K. The 
corresponding reaction model is shown in Appendix-C under Supplementary Information.
FAm reaction model. The proposed off-pathway reaction set is quite different from the on-pathway model and 
motivated by the experimental observations. In this model, at FAm range, the four Aβ monomers directly convert 
into the off-pathway oligomer ( ′A4) by reacting with micelles, L. These A s4′  can not able elongated any further. 
These reactions are shown in Appendix-E under Supplementary Information.
FApm reaction model. The modeling of off-pathway reactions at FApm zone is more challenging however; there 
are no existing models for off-pathway reactions at this zone. Furthermore, the behavior of aggregation, although 
sigmoidal, is much dissimilar than the on-pathway reaction in terms of the faster time-scale involved; the forma-
tion of 12–24 mers in this zone exhibit considerably less lag time and saturation time. We consider the following 
reactions at this range. In the first stage denoted as primary nucleation, the ′A4 form higher order oligomers ( ′A12) 
by monomer addition (i.e., adding A1). In the next stage, A12′  further elongates with the intermediate oligomers 
( ′A4– ′A11) to form higher order oligomers ( ′F1); this stage is termed as the elongation stage. Note that a F1′ is a mod-
eling abstraction and is of variable length; it’s length ranges from 16 mers to 23 mers (considering the addition of 
′ ... ′A A, ,4 11 each to A12). This results in a 6-fold increase in the oligomer size hosted by the pseudo-micelles as 
compared to the micelles (which can only host upto ′A4, whereas pseudo-micelles can host 23 mers) and is con-
sistent with the experimental observations on the diameters of pseudo-micelles and micelles. We next consider 
such ′F1  oligomers to laterally associate and create bigger oligomers ( ′F4); we term this stage as lateral association. 
As experimentally validated in Fig. 6, there is approximately a four-fold increase in oligomer size towards the 
beginning of the FApm dynamics after which the oligomer size goes down to that of A12′  and F1′; hence it is highly 
likely that the laterally associated ′F4 undergoes a secondary fragmentation into the lower order oligomer ″F1 .
It is noteworthy that F1″ is a structurally different species than F1′; the latter can laterally associate while the 
former cannot. This assumption was necessary to fit with the experimentally observed ThT kinetics data. 
Considering the secondary fragmentation to produce F1′ instead of F1″ could not correlate the simulation plots 
with the experimentally observed ThT dynamics. The set of near-CMC reactions are shown in Appendix-D under 
Supplementary Information.
Thus, the model at the near-CMC range deals with several rate constants and parameters. There are four rate 
constants for on-pathway reactions: (i) forward and backward rate constants of pre-nucleation reaction (knuon, 
knuon_) from the on-pathway; (ii) forward and backward rate constants of elongation reactions (kfbon, kfbon_) from 
the on-pathway; (iii) forward and backward rate constants of pre-nucleation in the off-pathway (kcon and kcon_); 
(iv) forward and backward rate constants of nucleation reactions (knouff, knouff_); (v) forward and backward rate 
constants of elongation reactions (kfboff, kfboff_) (vi) forward and backward rate constants of lateral association reac-
tions (keloff, keloff_); (vii) forward and backward rate constants of secondary fragmentation (kfagoff, kfagoff_); (viii) the 
fatty acid effect on the on-pathway rate constant parameter, K; and finally (ix) the pseudo-micelle concentration: 
p. Note that, the estimation of the pseudo-micelle concentration from the CMC values of fatty acids poses a dif-
ferent problem and needs controlled experimentation; however, it is biophysically not possible to exactly measure 
the pseudo-micelle concentration. We could only measure the diameter of pseudo-micelles. Hence we considered 
p as a free parameter along with the other rate constants to estimate the pseudo-micelle concentration.
Parameter estimation. It is difficult to estimate the proper rate constant values of all these parameters at 
once. Hence, we follow our divide and conquer strategy from ref. 10 to determine all the rate constants step by 
step. First, we matched the experimental data of the control experiment with the simulation considering the 
on-pathway reaction setup only and estimated the four rate constants involved in the on-pathway reactions. 
Subsequently, we used these values in the combined on-off-pathway model to estimate all the additional rate 
constants. More precisely, our simulation involves the steps below:
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 1. First, determine the rate constants for the on-pathway reactions from control experiment data.
 2. Estimate the parameter K for the FAn experimental data by using the estimated on-pathway rate constants.
 3. Estimate the rate constants of off-pathway aggregation with FApm experimental data utilizing the estimated 
on-pathway rate constants above.
 4. Validate the formation of off-pathway oligomers ( ′A4) in FAm concentration using all the estimated rate 
constants.
We first calculated the reaction flux for all reactions at a particular stage; then using these reaction fluxes, the 
differential equations for the rate of change of concentration is formulated for each oligomer. Next, these differential 
equations were solved using MATLAB’s ode solver and the R2 value between the simulated curve and experimental 
data was calculated for the different rate constant combinations. We solved these differential equations for various 
rate constant combinations with each rate constant ranging from 10−5 to 105 and the pseudo-micelle concentration 
p from 1 to 100 μM with multiples of 5. After that, these rate constants were manually fine-tuned to better match 
the experimental data and obtain better rate constant estimates. The best-fitted simulation parameters are taken as 
estimated rate constants of these reactions; each of these parameters are reported in the Appendices under the corre-
sponding reaction models. Moreover, all the rate constants estimated here by fitting with experimental ThT intensity 
plots required a mapping of the cumulative effects of the concentration of higher order ThT positive oligomers to the 
ThT values; such mapping is explained in Appendix-F in the Supplementary Information.
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